Funding Impact The Foundation for Sarcoidosis Research (FSR) has a broad fundraising footprint with reported revenue in the high hundreds of millions, indicating significant capacity for large-scale sponsorship, grant partnerships, and program funding opportunities aligned with corporate social responsibility goals.

Research Collaboration FSR emphasizes research funding and partnerships, presenting clear openings for pharmaceutical, biotech, and contract research organizations to collaborate on sarcoidosis studies, clinical trials, patient registries, and sponsor-led research initiatives.

Patient Support Expansion Recent and ongoing partnerships focus on expanding insurance and disability support for patients, creating sales angles for insurers, benefit consultancies, and healthcare navigation platforms to co-develop end-to-end patient assistance solutions.

Awareness and Events FSR actively engages the community through annual meetings, summits, and galas, offering opportunities for event sponsorship, digital marketing packages, and educational content collaborations with healthcare media and professional societies.

Strategic Partnerships The organization has formed or pursued alliances with major healthcare institutions and associations (Academic centers, ATS, Cedars-Sinai, Walgreens) indicating openness to multi-stakeholder initiatives, channel partnerships, and joint programs that can be leveraged for product demonstrations, awareness campaigns, or patient access programs.